LETTER TO THE EDITOR

Rebuttal to “The role of direct oral anticoagulants in the management of cancer-associated thrombosis’

BJMO - volume 13, issue 3, may 2019

M. Schapira MD

Concerning the review published in BJMO issue 2, March 2019:

The role of direct oral anticoagulants in the management of cancer-associated thrombosis

A. Awada, J-F. Baurain, P. Clement, P. Hainaut, S. Holbrechts, K. Jochmans, V. Mathieux, J. Mebis, M. Strijbos, C. Vulsteke, T. Vanassche, P. Verhamme (BELG J MED ONCOL 2019;13(2):46-53)

(BELG J MED ONCOL 2019;13(3):83)

Read more

Considerations on the use of low molecular weight heparins in patients with cancer and chronic kidney disease

BJMO - volume 10, issue 7, november 2016

J-M. Hougardy , S. Motte

(BELG J MED ONCOL 2016;10(7):240–242)

Read more

Rebuttal to ‘The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?’

BJMO - volume 7, issue 3, july 2013

A. Hugo MD

Concerning the previously published letter to the editor:

The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?

L. Van den Hove, Belg J Med Oncol 2013;7(1):3–7

(BELG J MED ONCOL 2013;7(3):72–73)

Read more

Concerning a previously published Introduction

BJMO - volume 7, issue 1, february 2013

J. De Grève MD, PhD

(BELG J MED ONCOL 2013;7:3-7)

Read more

Practical issues in the approach of the axilla

BJMO - volume 7, issue 1, february 2013

W. Tjalma MD, PhD

Concerning the previously published article:
Smeets A, Carly B, Cocquyt V, et al. The changing role of axillary dissection in the treatment of breast cancer. Belg J Med Oncol 2012;6:78–95

(BELG J MED ONCOL 2013;7:8–9)

Read more

Concerning a previously published practice guidelines article

BJMO - volume 6, issue 5, october 2012

C. Colpaert MD, PhD, K. Lambein MD, PhD, on behalf of the Belgian Working Group for Breast Pathology

(BELG J MED ONCOL 2012;6:183-184)

Read more

Comment on a previously published practice guidelines article

BJMO - volume 6, issue 4, september 2012

B. Lelie MD

Read more
X